Pure Bioscience (OTCMKTS: PURE) and Orion Engineered Carbons (NYSE:OEC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.

Volatility & Risk

How to Become a New Pot Stock Millionaire

Pure Bioscience has a beta of -1.34, suggesting that its share price is 234% less volatile than the S&P 500. Comparatively, Orion Engineered Carbons has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500.

Dividends

Orion Engineered Carbons pays an annual dividend of $0.80 per share and has a dividend yield of 2.8%. Pure Bioscience does not pay a dividend. Orion Engineered Carbons pays out 49.1% of its earnings in the form of a dividend.

Institutional and Insider Ownership

0.2% of Pure Bioscience shares are held by institutional investors. Comparatively, 86.6% of Orion Engineered Carbons shares are held by institutional investors. 10.6% of Pure Bioscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Pure Bioscience and Orion Engineered Carbons’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pure Bioscience -460.07% -260.04% -168.32%
Orion Engineered Carbons 5.69% 123.23% 9.03%

Earnings & Valuation

This table compares Pure Bioscience and Orion Engineered Carbons’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pure Bioscience $1.83 million 25.66 -$6.26 million ($0.10) -6.90
Orion Engineered Carbons $1.33 billion 1.27 $75.53 million $1.63 17.37

Orion Engineered Carbons has higher revenue and earnings than Pure Bioscience. Pure Bioscience is trading at a lower price-to-earnings ratio than Orion Engineered Carbons, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Pure Bioscience and Orion Engineered Carbons, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pure Bioscience 0 0 0 0 N/A
Orion Engineered Carbons 0 2 6 0 2.75

Orion Engineered Carbons has a consensus price target of $28.43, indicating a potential upside of 0.38%. Given Orion Engineered Carbons’ higher probable upside, analysts plainly believe Orion Engineered Carbons is more favorable than Pure Bioscience.

Summary

Orion Engineered Carbons beats Pure Bioscience on 12 of the 15 factors compared between the two stocks.

About Pure Bioscience

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a antimicrobial food processing aid for use in poultry processing and produce processing; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces; and SILV√ČRION, an antimicrobial solution used against bacteria, viruses, yeast, and molds. It sells its products to distributors and end users. PURE Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.

About Orion Engineered Carbons

Orion Engineered Carbons S.A., together with its subsidiaries, produces and sells carbon black products in Germany, the United States, South Korea, Brazil, China, South Africa, the rest of Europe, and internationally. It operates through two segments, Specialty Carbon Black and Rubber Carbon Black. The company offers post-treated specialty carbon black grades for coatings and printing applications; and various conductive carbon black grades for use in polymer and printing applications, as well as in silicon, non-woven textile, building material, battery electrodes metallurgical, agrochemical, and carbon brush applications. It also provides rubber carbon black products for applications in mechanical rubber goods under the PUREX brand, as well as in tires under the ECORAX brand name. The company was formerly known as Orion Engineered Carbons S.à r.l. and changed its name to Orion Engineered Carbons, S.A. in July 2014. Orion Engineered Carbons S.A. was incorporated in 2011 and is headquartered in Luxembourg. Orion Engineered Carbons S.A. is a subsidiary of Kinove Luxembourg Holdings 1 S.a r.l.

Receive News & Ratings for Pure Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pure Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.